Skip to main content
. Author manuscript; available in PMC: 2021 May 1.
Published in final edited form as: Value Health. 2020 Mar 20;23(5):559–565. doi: 10.1016/j.jval.2020.01.017

Table 2.

Strategy for analyzing the impact of population newborn genomic sequencing (nGS) on downstream health care costs.

Step BabySeq Project Implementation
1. Define relevant conditions
 Primary conditions Conditions identified prior to disclosure for which care may be influenced by nGS
• Existing diagnoses
• Family histories suggestive of possible genetic disease
 Secondary conditions Conditions identified during disclosure for which care may be influenced by nGS
• Unexpected monogenic disease risks
• Manifesting carrier status
2. Identify relevant services For each primary and secondary condition, develop patient-specific lists of services that may be used for
• Diagnosis
• Screening
• Treatment
Services of interest are identified based on review of
• GeneReviews [28],
• Online Mendelian Inheritance in Man [29]
• National Comprehensive Cancer Network guidelines [30]
• UpToDate [31]
3. Quantify health care utilization Record how often the relevant services were received by each patient based on
• Medical records reviews
• Family self-report
 ○ Surveys
 ○ Periodic calls with families
 ○ 10-month check-in
• Provider surveys